Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Back to our regularly scheduled program

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Jan 05, 2024 1:32am

142 Views

Post# 35811894

RE:Back to our regularly scheduled program

The ignore button works wonders. Should have used it much earlier on the tree guy !

Now down to just putting up with the HOBBS

where did Hmmmmm go BTW? He was misguided and prone to bad math, but at least he was somewhat coherent.

Anyway...

Regarding P/S and EBITDA multiples, I wonder if a price could be worked out between two parties based on a reasonable multiple of future projected sales ( or EBITDA) assuming approval after 150?

#savethesizzle

MM

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale